• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Chagas Disease Screening for Family Members of Positive Blood Donors

April 10, 2019

Chagas disease (CD) is a zoonotic infection caused by blood sucking Trypanosoma cruzi—a parasite that infects over 6 million people in the Americas, including at least 300,000 in the United States.  Transmission can also occur via blood transfusions, organ transplants, or via mother-to-child transmission.  Antitrypanosomal drugs given early can cure the disease, but CD that is left untreated often leads to heart failure.  Since the infection may be asymptomatic, many cases of CD are not treated.  In the United States, less than 1% of infected individuals have been diagnosed and treated.  Since family members of infected individuals often share risk factors for CD, researchers in Los Angeles assessed the prevalence of CD among 189 family members of 86 infected blood donors.  Overall, 7.4% (14/189) of these family members were positive for CD.  Although blood donations have been screened for CD in the US since 2007, further screening of family members of infected donors may be beneficial in identifying new cases.

Reference:

Hernandez S, Forsyth CJ, Flores CA, and SK Meymandi. Prevalence of Chagas disease among family members of previously diagnosed patients in Los Angeles, California. Clinical Infectious Disease 2019

Filed Under

  • Blood Donation
  • News
  • Transfusion Transmitted Infections

Recommended

  • Donor-Specific Antibody Levels and Platelet Transfusion Response Among Refractory Patients

  • Transfusion of Older Red Blood Cells Do Not Effect Long Term Survival of Cardiac Surgery Patients

  • Donor Lymphocytes May Play a Large Role in Transfusion-Associated Graft-Versus-Host Disease

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Ferritin Levels Needed to Assess Hemoglobin Recovery after Blood Donation

  • Transfusion of RBCs from Cord Blood May Protect Low-Weight Preterm Infants from Severe Retinopathy

  • AABB Guidelines Recommend Liberal RBC Transfusion for Patients with Acute Myocardial Infarction

  • Artificial Intelligence to Predict Immunogenicity of Amino Acid Substitutions of Blood Group Antigens

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley